Particularly, in the case of VHL disease, we have published the case of a 76-year-old woman in which a mutation in CLN5 (ceroid lipofuscinosis, neuronal, 5) offers a protective effect, preventing VHL-related tumour development [4]. The gene discussed is CLN5; the disease is neoplasm.